![]() |
RADAR (UK-MRA Myeloma XV)
Principal Investigator: Dr Arun Alfred Sponsor: University of Leeds Comparing treatment escalation and de-escalation strategies in newly diagnosed patients with multiple myeloma. |
FLAIR: A trial of ibrutinib with rituximab for chronic lymphocytic leukaemia
Principal Investigator: Dr Kathryn Goddard Sponsor: University of Leeds This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL). |
PROPEL
Principal Investigator: Dr James Taylor Sponsor: University of Warwickshire & University Hospitals Coventry and Warwickshire This trial aims to establish the clinical impact and cost-effectiveness of best practice usual care compared to a multiphasic multimodal personalised prehabilitation care package on fatigue, emotional wellbeing and quality of life in patients in remission following induction chemotherapy. |